Association of radiological type of dural tail sign in contrast MRI with histopathological grading of intracranial meningiomas
DOI:
https://doi.org/10.18203/2320-6012.ijrms20241527Keywords:
Asymmetrical multipolar, Histopathological grade, Meningioma, Nodular hyperplasia, Tumor morphologyAbstract
Background: In neurosurgical practice meningiomas are one of the commonest intracranial tumors to seek surgical intervention which is classified into 3 histological grades and 15 subtypes according to the 2016 WHO classification of tumors of the CNS. The aim of this study was to evaluate the association between radiological type of dural tail sign in contrast MRI with histopathological grading of intracranial meningiomas.
Methods: This was a cross sectional interventional study carried out in the Department of Neurosurgery, Bangabandhu Sheikh Mujib Medical University, Dhaka, Dhaka Medical College Hospital and National Institute of Neuroscience Hospital including 35 patients of intracranial meningiomas who fulfilled the selection criteria were enrolled in this study.
Results: This study included 35 cases of intracranial meningiomas. There were 22 individuals (62.9%) in the 28-47 age group. The mean±standard deviation (SD) age of the participants was 45.97±9.56 years. There were 9 male participants (25.7%) and 26 female participants (74.3%) with ratio 1:3. We see that parasagittal location (50%) and sphenoid wing (33.3%) were more prevalent in grade II. We found significant distribution of the types of DTS among the histological grades of meningioma. The nodular cases (6,100%) were all grade II type. Mixed type was the most prevalent type among grade I.
Conclusions: There is association of radiological type of dural tail sign in contrast MRI with histopathological grading of intracranial meningiomas and may be used as a good tools for forecasting tumor type and prognosis.
Metrics
References
Hoover JM, Morris JM, Meyer FB. Use of preoperative magnetic resonance imaging T1 and T2 sequences to determine intraoperative meningioma consistency. Surg Neurol Int. 2011;2.
Baldi I, Engelhardt J, Bonnet C, Bauchet L, Berteaud E, Grüber A, Loiseau H. Epidemiology of meningiomas. Neurochir. 2018;64(1):5-14.
Alexiou GA, Gogou P, Markoula S, Kyritsis AP. Management of meningiomas. Clin Neurol Neurosurg. 2010;112(3):177-82.
Whittle IR, Smith C, Navoo P, Collie D. Meningiomas. The Lancet. 2004;363(9420):1535-43.
Buerki RA, Horbinski CM, Kruser T, Horowitz PM, James CD, Lukas RV. An overview of meningiomas. Future Oncol. 2018;14(21):2161-77.
Strowd III RE, Blakeley JO. Common histologically benign tumors of the brain. CONTINUUM: Life Learn Neurol. 2017;23(6):1680-708.
Fathi AR, Roelcke U. Meningioma. Curr Neurol Neurosci Repor. 2013;13(4):1-8.
Husni H, Hamrahian AH. Dural tail sign in meningiomas. AACE Clin Case Rep. 2021;7(3):226-7.
Doddamani RS, Meena RK, Sawarkar D. Ambiguity in the dural tail sign on MRI. Surg Neurol Int. 2018;9:67.
Qi ST, Liu Y, Pan J, Chotai S, Fang LX. A radiopathological classification of dural tail sign of meningiomas. J Neurosurg. 2012;117(4):645-53.
Chamberlain MC. Chemotherapy for Intracranial Meningiomas. In: McDermott MW, Al-Mefty O. (eds.) Al-Mefty’s Meningiomas. Thieme Medical Publishers, Inc. 2011:382-404.
Goyal N, Satyarthee GD, Kakkar A, Vaishali SU, Chandra S, Sharma B. Mount meningioma with tumor cap. Turk Neurosurg. 2014;24(3).
Pieper DR, Al-Mefty O, Hanada Y, Buechner D. Hyperostosis associated with meningioma of the cranial base: secondary changes or tumor invasion. Neurosurg. 1999;44(4):742-6.
Moradi A, Semnani V, Djam H, Tajodini A, Zali AR, Ghaemi K, et al. Pathodiagnostic parameters for meningioma grading. J Clin Neurosci. 2008;15(12):1370-5.
Prabhu VC, Perry EC, Melian E, Barton K, Guo R, Anderson DE. Intracranial meningiomas in individuals under the age of 30; analysis of risk factors, histopathology, and recurrence rate. Neurosci Disc. 2014;2(1):1-5.
Huang MC, Loveren HR. Convexity Meningiomas. In: McDermott MW, Al-Mefty O. (eds.) Al-Mefty’s Meningiomas. Thieme Medical Publishers, Inc. 2011:26.
Magill ST, Young JS, Chae R, Aghi MK, Theodosopoulos PV, McDermott MW. Relationship between tumor location, size, and WHO grade in meningioma. Neurosurg Focus. 2018;44(4):E4.
Greenberg MS. Handbook of neurosurgery. 10th ed. New York: Thieme. 2023:803-805.